Aperture Financial Statements From 2010 to 2025

ELNX Stock  USD 0.06  0.00  0.00%   
Aperture Health financial statements provide useful quarterly and yearly information to potential Aperture Health investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Aperture Health financial statements helps investors assess Aperture Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Aperture Health's valuation are summarized below:
Aperture Health does not presently have any fundamental signals for analysis.
Check Aperture Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aperture Health's main balance sheet or income statement drivers, such as , as well as many indicators such as . Aperture financial statements analysis is a perfect complement when working with Aperture Health Valuation or Volatility modules.
  
This module can also supplement various Aperture Health Technical models . Check out the analysis of Aperture Health Correlation against competitors.

Aperture Health Company Beta Analysis

Aperture Health's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

 = 

Covariance

Variance

More About Beta | All Equity Analysis

Current Aperture Health Beta

    
  18.97  
Most of Aperture Health's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aperture Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, Aperture Health has a Beta of 18.97. This is much higher than that of the Industrials sector and notably higher than that of the Metal Fabrication industry. The beta for all United States stocks is notably lower than that of the firm.

Aperture Health Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Aperture Health's current stock value. Our valuation model uses many indicators to compare Aperture Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aperture Health competition to find correlations between indicators driving Aperture Health's intrinsic value. More Info.
Aperture Health is rated as one of the top companies in current valuation category among its peers. It also is one of the top stocks in price to sales category among its peers fabricating about  0.05  of Price To Sales per Current Valuation. The ratio of Current Valuation to Price To Sales for Aperture Health is roughly  21.70 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Aperture Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aperture Health's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Aperture Health Financial Statements

Aperture Health investors use historical fundamental indicators, such as Aperture Health's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Aperture Health. Please read more on our technical analysis and fundamental analysis pages.
CSS Alliance LLC operates as a Steel management services organization and manages manufacturing of companies. Elinx Corp is traded on OTC Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Aperture Pink Sheet Analysis

When running Aperture Health's price analysis, check to measure Aperture Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aperture Health is operating at the current time. Most of Aperture Health's value examination focuses on studying past and present price action to predict the probability of Aperture Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aperture Health's price. Additionally, you may evaluate how the addition of Aperture Health to your portfolios can decrease your overall portfolio volatility.